Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced cardiocirculatory complications with unrestrictive visiting policy in an intensive care unit: results from a pilot, randomized trial.
Fumagalli S, Boncinelli L, Lo Nostro A, Valoti P, Baldereschi G, Di Bari M, Ungar A, Baldasseroni S, Geppetti P, Masotti G, Pini R, Marchionni N. Fumagalli S, et al. Among authors: geppetti p. Circulation. 2006 Feb 21;113(7):946-52. doi: 10.1161/CIRCULATIONAHA.105.572537. Circulation. 2006. PMID: 16490836 Clinical Trial.
Alfuzosin (10 mg) does not affect blood pressure in young healthy men.
Mondaini N, Giubilei G, Ungar A, Gontero P, Cai T, Gavazzi A, Bartoletti R, Geppetti P, Carini M. Mondaini N, et al. Among authors: geppetti p. Eur Urol. 2006 Dec;50(6):1292-6; discussion 1297-8. doi: 10.1016/j.eururo.2006.06.016. Epub 2006 Jun 28. Eur Urol. 2006. PMID: 16837126 Clinical Trial.
[β-blockers: a new and emerging treatment for melanoma].
De Giorgi V, Gandini S, Grazzini M, Benemei S, Marchionni N, Geppetti P. De Giorgi V, et al. Among authors: geppetti p. Recenti Prog Med. 2012 Jan;103(1):11-6. doi: 10.1701/1022.11152. Recenti Prog Med. 2012. PMID: 22322621 Italian.
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.
Lapi F, Cipriani F, Caputi AP, Corrao G, Vaccheri A, Sturkenboom MC, Di Bari M, Gregori D, Carle F, Staniscia T, Vestri A, Brandi M, Fusco V, Campisi G, Mazzaglia G; Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group. Lapi F, et al. Osteoporos Int. 2013 Feb;24(2):697-705. doi: 10.1007/s00198-012-2013-y. Epub 2012 May 23. Osteoporos Int. 2013. PMID: 22618266
418 results